Shu‐Biao Wu
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Molecular Biology top 10%
- RNA modifications and cancer 6
- Cancer-related gene regulation 5
- Wnt/β-catenin signaling in development and cancer 4
- RNA Research and Splicing 4
- Aging top 10%
- Oncology top 10%
- Cancer Cells and Metastasis 4
- Cancer-related Molecular Pathways 4
-
- Telomeres, Telomerase, and Senescence 6
- Journals
- Nucleic Acids Research (2 papers)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesMexico
In The Last Decade
Shu‐Biao Wu
52 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 88
- Cancer Research 457
- Molecular Biology 841
- Aging 20
- Oncology 294
- Immunology 146
Countries citing papers authored by Shu‐Biao Wu
This map shows the geographic impact of Shu‐Biao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Biao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Biao Wu more than expected).
Fields of papers citing papers by Shu‐Biao Wu
This network shows the impact of papers produced by Shu‐Biao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Biao Wu. The network helps show where Shu‐Biao Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shu‐Biao Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 23 | |
| 11 | 2020 | 10 | |
| 12 | 2019 | 17 | |
| 13 | 2016 | 67 | |
| 14 | 2016 | 24 | |
| 15 | 2015 | 16 | |
| 16 | 2015 | 30 | |
| 17 | 2015 | 43 | |
| 18 | 2015 | 21 | |
| 19 | 2015 | 7 | |
| 20 | 2014 | 85 |
About Shu‐Biao Wu
Shu‐Biao Wu is a scholar working on Cancer Research, Immunology and Allergy and Molecular Biology, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Telomeres, Telomerase, and Senescence (6 papers), RNA modifications and cancer (6 papers), Cancer-related gene regulation (5 papers), Cancer Cells and Metastasis (4 papers), Cancer-related Molecular Pathways (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Cancer Research (457 citations), Molecular Biology (841 citations) and Aging (20 citations). Shu‐Biao Wu has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Libing Song, Jinrong Zhu, Xin Zhang, Chuyong Lin, Fangyong Lei, Liping Ye, Aibin Liu, Junling Liu, Yuanlong Ge and Xi Lin. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.